D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Jack Dorsey is making a concrete bet that artificial intelligence can replace what middle managers have done in large organizations for generations. Block’s chief executive, writing jointly with lead independent director Roelof Botha, has outlined a structural transformation in which AI takes on work currently handled by layers of human management. That means moving information, tracking progress and generating real-time operational visibility across the entire business, without a manager in the middle. The case they make starts with a critique of hierarchy itself. Management layers were designed to solve an information problem. In large organizations, someone has to gather data, relay it upward and translate decisions back down. Dorsey and Botha pushed back against the interpretation that this makes people peripheral. They argued that judgment calls on values, ethics and strategy cannot be handed to a machine regardless of how capable AI systems become. The most consequential decisions will continue to require human reasoning and accountability. People would operate where ambiguity and consequence are highest, while the AI manages the operational machinery underneath. Acknowledging that the model is unproven and the path toward it messy, Dorsey and Botha framed the shift as genuinely significant. What they are proposing is structuring operations around an intelligence platform instead of conventional management tiers, representing a fundamentally new organizational concept. If it holds at scale, the implications would reach well beyond Block. Given that the company has already restructured thousands of jobs around this premise, the experiment is well underway whether the theory ultimately holds or not. With more disruptive technologies like quantum computing being developed by enterprises like D-Wave Quantum Inc. (NYSE: QBTS), the employment landscape could undergo further transformation in the coming years. 

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

• Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
• Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
• Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $14.57, up 6.0408%, on 21,807,932 volume. The average volume for the last 3 months is 21,412,647 and the stock's 52-week low/high is $5.97/$46.75.

Recent News

• D-Wave Quantum Inc. (NYSE: QBTS) - Block Co-Founder Foresees AI Doing Middle Management Tasks
• California Defies Trump, Institutes Its Own Rules on AI
• Stocks of Memory Chip Manufacturers See Red as Supply Shortages Ease

Greenland Energy Company (NASDAQ: GLND)

The QualityStocks Daily Newsletter would like to spotlight Greenland Energy Company (NASDAQ: GLND).

Editorial coverage underscores geopolitical urgency and strategic role of Jameson Land Basin development

Greenland Energy (NASDAQ: GLND) is featured in a recent NetworkNewsWire editorial examining how renewed geopolitical instability and disruptions around key chokepoints such as the Strait of Hormuz are reinforcing the fragility of global energy supply chains. The editorial highlights growing urgency among U.S. and European policymakers to diversify supply and strengthen domestic production, positioning Greenland Energy’s exploration efforts in the Jameson Land Basin within the broader push toward long-term energy independence. According to the NetworkNewsWire coverage, the Jameson Land Basin is estimated to hold up to 13 billion barrels of oil potential, underscoring its significance as a large-scale, underexplored resource. With recent developments including secured drilling capacity and plans to drill key wells, Greenland Energy is advancing toward unlocking this potential while maintaining financial flexibility. The editorial notes that as major discoveries become increasingly rare, frontier exploration in stable regions such as Greenland is drawing heightened attention from investors and industry participants alike. The editorial also highlights Greenland Energy alongside major industry players pursuing frontier exploration, including Exxon Mobil Corporation (NYSE: XOM), Shell PLC (NYSE: SHEL), Chevron Corporation (NYSE: CVX) and BP PLC (NYSE: BP), underscoring a broader industry shift toward unlocking new energy supplies in stable jurisdictions as global demand and geopolitical risks continue to shape the energy landscape.

To view the full editorial, visit https://nnw.fm/xZn4n

Greenland Energy (NASDAQ: GLND) visited the Nasdaq MarketSite in Times Square to celebrate its recent public listing, with CEO Robert Price, Executive Chairman Larry G. Swets, Jr., and Executive Advisor Joe Moglia ringing the Opening Bell. The milestone highlights the company’s focus on advancing hydrocarbon exploration in Greenland’s Jameson Land Basin, a large-scale, underexplored asset believed to represent a significant new onshore energy opportunity. In a recent interview, Price pointed to near-term momentum, including plans to drill two initial wells in 2026 following extensive logistical preparation, noting the basin spans roughly 2 million acres with multiple identified targets supported by legacy seismic data and modern reprocessing, positioning the company to initiate its first exploration campaign.

Greenland Energy Company (NASDAQ: GLND) is an exploration-focused oil and gas company targeting development in Greenland’s Jameson Land Basin, a large and historically underexplored hydrocarbon region in the Arctic. The company was formed through the completed business combination of Pelican Acquisition Corporation, Greenland Exploration Limited, and March GL Company, creating a publicly traded platform designed to pursue large-scale resource opportunities.

The company’s vision is to responsibly unlock Greenland’s energy potential, supporting both local development and global energy security through science-driven exploration and innovation.

The company is working to progress exploration across the Jameson Land Basin, which has been studied extensively but remains undrilled, combining historical geological work with modern seismic analysis and planned drilling programs. Its efforts are focused on unlocking the hydrocarbon potential identified through decades of prior research while progressing toward initial well development.

With a technical foundation supported by historical exploration and active operational planning, Greenland Energy is positioning itself to advance one of the largest undrilled onshore basins in the Arctic.

The company is headquartered in Denver, Colorado.

Projects

Greenland Energy Company is focused on the exploration and development of oil and gas resources in Greenland’s Jameson Land Basin, which includes more than two million acres across three onshore licenses covering the entire petroleum basin.

Greenland Energy is committed to responsible resource development through close collaboration with local communities, strict adherence to Arctic environmental regulations, and the use of technologies designed to reduce exploration impact. The company aims to balance energy advancement with environmental and social integrity.

The basin has been the subject of extensive historical exploration conducted by Atlantic Richfield (ARCO) between the 1970s and 1990s, with more than $275 million (inflation adjusted) invested in seismic acquisition, field mapping, and evaluation programs. This work identified multiple large hydrocarbon targets but did not advance to drilling.

Greenland Energy has reprocessed approximately 1,800 kilometers of legacy seismic data using modern imaging technology identifying more than 50 oil and gas leads and prospects. The basin has been described as having geological similarities to major producing regions such as the North Sea and Alaska’s Prudhoe Bay.

The company has secured rights through agreements with 80 Mile and its subsidiary White Flame Energy A/S to earn up to a 70% interest in the basin. These rights are tied to the drilling of two exploration wells designed to delineate the sedimentary structure and resource potential.

Operational planning is underway, including the mobilization of heavy equipment and the preparation of infrastructure to support drilling activities. The company has engaged Halliburton to support logistics planning and drilling services, retained IPT Well Solutions for project management oversight, and engaged Stampede Drilling for drilling operations, alongside additional logistics and service providers.

Market Opportunity

According to company materials, the Arctic region contains approximately 13% of the world’s undiscovered conventional oil resources, representing about 90 billion barrels, and 30% of its undiscovered conventional natural gas resources.

Within this broader context, the Jameson Land Basin represents a large, historically underexplored region with identified hydrocarbon potential. Independent engineering analysis from Sproule ERCE indicates upside of approximately 13 billion barrels of recoverable oil within the basin, subject to exploration and development outcomes.

Leadership Team

Robert Price, Chief Executive Officer, has assembled and managed companies across the energy, real estate, and manufacturing sectors and founded Brooks Energy Company in 1991. He previously served as Vice President, Trust Officer, and Oil and Gas Trust Energy Department Manager at the First National Bank and Trust Company of Tulsa, now J.P. Morgan Chase Bank, and has overseen the reprocessing of approximately 1,800 kilometers of seismic data from the Jameson Land Basin.

Larry G. Swets Jr., Executive Chairman, has been involved in advancing the development of energy resources in Greenland’s Jameson Land Basin through Greenland Exploration Limited and its combination with March GL Company and Pelican Acquisition Corporation.

Greenland Energy Company (NASDAQ: GLND), closed Wednesday's trading session at $8.64, up 19.8336%, on 1,338,475 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $6.5/$23.

Recent News

• Greenland Energy Company (NASDAQ: GLND) - MissionIRNewsBreaks - Greenland Energy Company (NASDAQ: GLND) Marks Nasdaq Debut With Opening Bell Ceremony
• NetworkNewsBreaks - Greenland Energy Company (NASDAQ: GLND) Positioned at Center of Energy Independence Push Amid Global Supply Risks
• Greenland Energy Company (NASDAQ: GLND) Is 'One to Watch'

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)

Disseminated on behalf of Canamera Energy Metals Corp., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF).

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) has completed a 463.7 line-kilometre airborne magnetic survey at its Garrow rare earth element project in eastern Ontario, identifying a broad magnetic anomaly coincident with elevated total rare earth element values from Ontario Geological Survey lake sediment data, providing a key target for follow-up exploration as the company advances its data-driven strategy across its Ontario asset portfolio.

To view the full press release, visit https://ibn.fm/J6Bmf

Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) is a rare earth and critical metals exploration company focused on developing a diversified portfolio of district-scale opportunities across the Americas. The company targets jurisdictions with supportive regulatory frameworks, strong geological signatures, and increasing strategic relevance as global supply chains seek alternatives to China’s rare earth dominance. Its assets span ionic clay systems in Brazil, carbonatite complexes in the United States and Canada, and underexplored terrains with meaningful geophysical and geochemical indicators.

Guided by a vision to support North American and allied rare earth supply chains, Canamera concentrates on high-conviction targets where early entry, scalable land positions, and efficient exploration can potentially unlock long-term value. The company’s mission is centered on generating discoveries aligned with the accelerating global demand for critical minerals essential to defense, advanced manufacturing, clean energy technology, and next-generation electronics. Through systematic data-driven exploration, Canamera aims to advance projects aligned with growing efforts to diversify rare earth supply across strategic jurisdictions.

The company is headquartered in Edmonton, Alberta.

Projects

Turvolândia – Minas Gerais, Brazil

Canamera holds an option to acquire up to a 100% ownership interest in the Turvolândia Rare Earth Ionic Clay Project, a 29,574-hectare land package located in Minas Gerais, Brazil’s top mining state and a region responsible for over 30% of national mineral output. The project sits within a prolific corridor of REE-rich alkaline rocks associated with the Poços de Caldas Complex, currently being advanced by multiple industry developers.

Turvolândia benefits from year-round road access, established infrastructure, and supportive local communities. The geological setting includes the São Vicente and Pouso Alegre complexes, where heavily weathered horizons host REE-enriched clays and minerals such as monazite and bastnäsite.

Early exploration confirms REE-bearing clays, with upcoming work focused on property-wide soil sampling and deeper drilling to test the primary ionic clay enrichment horizon and depth potential.

São Sepé – Rio Grande do Sul, Brazil

Canamera also holds an option to acquire up to a 100% interest in the São Sepé Project, which comprises 7,966 hectares in a province known for significant mining activity, including coal, gems, and titanium, and offers strong infrastructure and accessibility. The geology is dominated by an 11-km Rapakivi granite body and advanced-weathered granitoid rocks prospective for potential ionic clay REE mineralization.

While currently undrilled, initial soil sampling indicates the presence of REE enrichment potential. Three priority targets—Erica, Sara, and Maya—have been identified, with planned work including systematic soil sampling and drilling across defined zones. The project also covers a notable uranium-potassium-thorium anomaly, further supporting its rare earth potential.

Iron Hills – Colorado, USA

The Iron Hills Project consists of 85 unpatented lode claims totaling 1,756 acres, held at 100% ownership and located within the Iron Hills / Powderhorn carbonatite complex, one of the premier carbonatite-alkaline systems in the United States. Adjacent to Teck Resources’ Iron Hill deposit, host to one of the country’s largest rare earth oxide and titanium deposits, the project spans two non-contiguous claim blocks positioned along mapped intrusive contacts, felsite porphyry boundaries, and carbonatite dike projections.

Canamera staked these claims in 2025 as part of its U.S. expansion strategy supported by Rangefront Mining Services, and they are pending approval by the BLM.

Schryburt Lake – Ontario, Canada

Through a Joint Venture Option Agreement, Canamera may earn up to a 90% interest in the Schryburt Lake Project, a multi-center carbonatite-hosted REE–Nb system defined by four priority targets: Blue Jay, Goldfinch, Blackbird, and Starling.

These prospects exhibit coincident thorium radiometric highs, coherent magnetic bodies, surface anomalies, and historical trenching. Together, they outline the potential for a vertically extensive and multi-center REE–Nb system. Planned work includes a ~1,000-meter heli-supported scout drilling program following permitting and community consultation.

Garrow – Ontario, Canada

The Garrow Project covers 2,182 hectares located 43 km north-northeast of North Bay and is accessible year-round with strong local infrastructure. Canamera holds an option to acquire a 100% interest in the property.

Regional geochemical datasets include 26 samples above 500 ppm REE across Ontario, and three of these high-value anomalies occur within the Garrow Township area, making it a compelling target for early-stage exploration, including property-wide soil sampling and geophysics to delineate initial drill targets.

Market Opportunity

Rare earth elements play a central role in high-growth industries including electric vehicles, wind turbines, robotics, high-performance electronics, defense systems, and medical imaging, underpinning global trends in electrification, automation, and advanced manufacturing. Their application in permanent magnets, optics and lasers, catalysts, and nuclear and medical technologies positions them as foundational materials for both industrial innovation and national security.

Global demand for rare earth elements is projected to triple—from 59,000 tonnes in 2022 to 176,000 tonnes by 2035—driven by rapid EV adoption and wind-power expansion, with supply expected to lag by up to 30%, according to McKinsey & Company. The global REE market, valued at $3.95 billion in 2024, is forecast to reach $6.3 billion by 2030 at a compound annual growth rate of approximately 8.6%, according to Grand View Research, reflecting a sustained and widening supply-demand imbalance that supports new project development.

China currently controls approximately 60% of global rare earth mining and about 90% of processing capacity, reinforcing persistent price volatility and supply-chain concentration that have been highlighted by historical export restrictions, environmental crackdowns, and geopolitical disruptions. In response, North American governments have accelerated initiatives to strengthen domestic critical-minerals supply chains, including $1 billion in U.S. Department of Energy funding opportunities and Canada’s C$1.5 billion Critical Minerals Infrastructure Fund. Together, these structural shortages, policy tailwinds, and long-term electrification trends underscore the strategic relevance of Canamera’s diversified rare earth portfolio across Brazil, the United States, and Canada.

Leadership Team

Brad Brodeur, CEO & Director, brings more than 27 years of capital markets experience focused on venture-stage issuers, having led over $100 million in financings for junior and start-up companies following senior advisory roles at Raymond James, Canaccord Genuity, and Edward Jones.

Warren Robb, VP Exploration, brings over 35 years of global mineral exploration experience across North America, China, Africa, and South America, including senior roles with Nexus Gold, WPC Resources (now Bluestar Gold), Roxgold, TTM Resources, Majestic Gold, and Trivalence Mining.

Jelena Veljovic, CFO, brings public-company financial reporting and accounting expertise through her work with Treewalk Consulting in Vancouver, supported by prior experience in taxation and private-company accounting at Focus LLP in Calgary.

All technical and scientific information disclosed herein was reviewed and approved by Warren Robb, P.Geo (British Columbia), Vice-President, Exploration, of the Company and a “Qualified Person” as defined by National Instrument 43-101.

For a discussion of the Company’s QA/QC and data verification processes and procedures, please see its most recently filed technical report, a copy of which is available under Canamera’s profile at www.sedarplus.ca.

Canamera Energy Metals Corp. (OTCQB: EMETF), closed Wednesday's trading session at $0.27036, up 3.9846%, on 29,453 volume. The average volume for the last 3 months is 179,130 and the stock's 52-week low/high is $0.2/$0.94.

Recent News

• Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) - MiningNewsBreaks - Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Identifies Magnetic Anomaly at Garrow REE Project
• MiningNewsBreaks - Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) Advances Multi-Project Exploration Portfolio Following $10.2 Million Financing
• Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Expands Ionic Clay Rare Earth Footprint in Brazil

Nightfood Holdings Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (OTCQB: NGTF).

Nightfood Holdings (OTCQB: NGTF) has been featured in an editorial published by AINewsWire, part of the Dynamic Brand Portfolio@IBN, highlighting the growing role of AI-enabled robotics in addressing evolving regulatory demands in pharmaceutical manufacturing. The coverage outlines increasing pressure from regulators, including stricter contamination control and data integrity requirements, and positions Nightfood, operating as TechForce Robotics, at the forefront of this shift with platforms that integrate autonomous systems, SOP intelligence and real-time deviation detection to support compliance and operational efficiency in next-generation GMP environments.

To view the full press release, visit https://ibn.fm/OHnV2

Nightfood Holdings Inc. (OTCQB: NGTF) is a hospitality technology and asset acquisition company revolutionizing hotel operations through AI-driven service robotics and strategic property acquisitions. By integrating advanced automation solutions with high-value hospitality assets, NGTF is setting a new standard for operational efficiency, cost reduction, and labor optimization in the hospitality industry.

With a focus on Robotics-as-a-Service (RaaS) and hotel ownership, NGTF is uniquely positioned at the intersection of technology and real estate, creating scalable, revenue-generating solutions that drive the widespread adoption of automation in the hospitality sector.

Operations

Nightfood Holdings is focused on two core business areas:

• Hotel Acquisitions & Operations – NGTF is acquiring a portfolio of independent hospitality properties, spanning various market segments from midscale to luxury. These hotels serve as real-world testbeds for automation technologies, allowing NGTF to refine its RaaS solutions before deploying them at scale.
• Robotics-as-a-Service (RaaS) for Hospitality – NGTF provides subscription-based, AI-driven robotic automation, designed to optimize hotel operations. By deploying standardized automation solutions, NGTF helps hotels reduce costs, improve labor efficiency, and enhance guest experiences.

Through this fully integrated model, NGTF ensures that its robotics solutions are tested, optimized, and proven profitable before expanding to third-party hotel operators.

Market Opportunity

The demand for automation in hospitality is accelerating, driven by labor shortages, rising costs, and increased competition. NGTF is positioned to capitalize on this shift through its combined hotel ownership and RaaS strategy.

• Total Addressable Market (TAM): The global service robotics market is projected to reach approximately $107.75 billion by 2030, driven by widespread adoption across industries including hospitality, according to Research and Markets.
• Serviceable Available Market (SAM): The global smart hospitality market, which includes AI and automation technologies for hotels, is projected to reach $186.10 billion by 2032, according to SNS Insider.
• Competitive Positioning: NGTF’s unique real estate + automation model allows it to implement cost-saving robotics solutions in real-world environments before expanding adoption across the industry.

Industry Impact: The Future of Smart Hotels

NGTF is at the forefront of next-generation hospitality automation, transforming how hotels operate. By combining AI-powered service robotics with real estate acquisitions, NGTF is pioneering the transition to smart, highly efficient hotel environments.

Hotels acquired by NGTF serve as testing grounds for robotics deployment, allowing the company to continuously refine its automation solutions. The biggest industry benefits include:

• Cost Savings for Hotel Operators – Reducing labor costs and improving operational efficiency.
• Scalability & Standardization – Offering a streamlined, subscription-based RaaS model for seamless automation adoption.
• Industry Leadership in Hotel Robotics – Driving the transformation of hospitality with AI-powered automation solutions.

Future Vision & Growth Strategy

Over the next three to five years, NGTF is committed to scaling both its hotel portfolio and RaaS adoption. By refining and optimizing its automation technologies in its own properties, NGTF will continue deploying RaaS to third-party hotel operators, positioning itself as a leader in next-generation hospitality automation.

Through strategic acquisitions and AI-driven solutions, NGTF is defining the future of smart hotels—delivering cost-efficient, scalable automation that reshapes the hospitality landscape.

Team Expertise as a Strategic Advantage

In addition to technology and real estate, NGTF’s most powerful asset is its team. The company’s leadership and operating partners bring deep expertise in both hospitality and food service, having collectively developed over 50 properties, managed more than 130 hotels, and supported more than 6,000 quick-service restaurants.

This wealth of experience enables NGTF to execute its automation and acquisition strategy with operational discipline, industry insight, and scale—further strengthening its position in next-generation hospitality.

Nightfood Holdings Inc. (OTCQB: NGTF), closed Wednesday's trading session at $0.031, up 6.1644%, on 784,463 volume. The average volume for the last 3 months is 487,460 and the stock's 52-week low/high is $0.0112/$0.114.

Recent News

• Nightfood Holdings Inc. (OTCQB: NGTF) - AINewsBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Featured in AINewsWire Editorial on AI-Enhanced Robotics in Pharma Manufacturing
• The Future of Service Is Already Here; TechForce Is Turning Robotics into Operational Infrastructure
• TechMediaBreaks - Nightfood Holdings Inc. (OTCQB: NGTF) Enters Robotics And AI Biopharma Partnership With Oncotelic Therapeutics (OTCQB: OTLC)

Frontieras North America Inc.

The QualityStocks Daily Newsletter would like to spotlight Frontieras North America Inc.

CEO Matthew T. McKean outlines Mason County as proof point for scalable, domestically sourced energy model built to benefit from volatility

Frontieras North America CEO Matthew T. McKean, in a newly released blog, details how recent global energy disruptions have exposed the structural weakness of crude-dependent systems while reinforcing the need for a more resilient—and antifragile—approach to energy production. As volatility drives sharp increases in diesel, naphtha and fertilizer prices, McKean emphasizes that the company’s FASForm platform is designed with a fundamentally different architecture: low, fixed-cost domestic coal feedstock paired with outputs priced against global markets, allowing revenues to rise even as input costs remain stable. The blog highlights the company’s Mason County, West Virginia, facility as the first commercial validation of this model, with plans to process 2.7 million tons of coal annually into a diversified mix of fuels, chemicals and advanced carbon products. McKean positions the project as more than a single development, describing it as a scalable blueprint for strengthening U.S. energy security by leveraging domestic resources and existing infrastructure to create a more stable, self-reliant and economically advantaged energy system.

To view the full blog post, visit https://ibn.fm/69mpL

Frontieras North America Inc. is an energy and environmental technology company focused on redefining how coal and other solid hydrocarbons are utilized within modern energy and industrial systems. Rather than treating coal as a fuel to be burned, the company applies patented processing technology to reform solid hydrocarbons into multiple market-ready energy and industrial products designed for existing global markets.

The company’s approach is rooted in extracting greater value from abundant natural resources through industrial innovation, addressing inefficiencies historically associated with conventional coal use. By separating coal into gases, liquids, and purified solid carbon, Frontieras positions coal as a versatile feedstock capable of supporting transportation, manufacturing, agriculture, and industrial infrastructure demand.

Frontieras emphasizes closed-loop, zero-waste processing as a means of producing energy products more efficiently while reducing emissions and unused byproducts.

Products and Projects

Frontieras’ core platform is FASForm™, a patented Solid Carbon Fractionation process that deconstructs coal by extracting volatiles, moisture, and contaminants. The process produces hydrogen, methane, naphtha, diesel, aviation fuel, and FASCarbon™, a low-sulfur technical carbon product.

The company is developing its first commercial-scale FASForm™ facility in Mason County, West Virginia, an estimated $850 million project designed to process approximately 7,500 tons of coal per day, or about 2.7 million tons annually. The facility is supported by a 10-year feedstock MOU using Pittsburgh #8 coal and a 10-year offtake LOI covering 100% of produced fuels, FASCarbon™, sulfuric acid, and fertilizer.

Engineering, construction, operations, logistics, and insurance partners are under executed agreements, and the project has completed FEL 1 and FEL 2, with substantial FEL 3 underway. Following its initial Mason County development, Frontieras plans to deploy additional FASForm™ facilities in West Virginia, Texas, and Wyoming, with longer-term international deployment in markets where its patent portfolio is in force.

Market Opportunity

Frontieras targets established global energy and chemicals markets with a combined estimated value exceeding $2.1 trillion. The company’s product portfolio aligns with large, existing demand across diesel, hydrogen, naphtha, jet fuel, technical carbon – coke, industrial chemicals, and fertilizer markets. These products are core industrial inputs with long-established supply chains, entrenched end-use applications, and global pricing benchmarks, reducing reliance on the creation of new or speculative markets.

These markets serve essential roles across transportation, agriculture, industrial machinery, aviation, steel manufacturing, petrochemicals, and food production, supporting continuous demand driven by infrastructure, manufacturing, and population growth. The planned design capacity of the first FASForm™ facility is approximately 7,500 tons per day, or about 2.7 million tons annually — equivalent to roughly 0.5% of current U.S. coal production. This design framework is intended to enable Frontieras to scale output incrementally while remaining aligned with existing market capacity, logistics networks, and demand profiles.

Leadership Team

Matthew McKean, Co-Founder & Chief Executive Officer, leads Frontieras’ overall strategy and execution and brings more than 25 years of experience across finance, operations, and business leadership. He previously co-founded a mortgage banking firm that grew into one of the largest originators in the southwestern U.S. before a successful exit, followed by senior leadership roles within large real estate finance organizations. McKean has been an active member of the CEO mentoring organization Vistage, advising companies across construction, finance, infrastructure, and consumer sectors. He holds a Bachelor of Science in Human Nutrition with an emphasis in Chemistry from Arizona State University and completed pre-med coursework.

Josephe Witherspoon, P.E., Co-Founder & Chief Technology Officer, is the inventor of the FASForm™ process and the author of the company’s core patents. He brings extensive experience in petroleum refining, natural gas processing, and chemical engineering from senior roles at Chevron, Enterprise Products, Sinclair Oil, and Marathon Petroleum. As a Process Design Engineer and Major Capital Project Manager, Witherspoon has led projects delivering significant operational and economic improvements. He holds a Bachelor of Science in Chemical and Fuels Engineering from the University of Utah and is a licensed Professional Engineer.

Andrea Moran, Chief Commercial Officer, oversees Frontieras’ commercialization strategy, capital formation, and go-to-market execution. She brings more than 25 years of experience in operations, management, and business development across the energy and infrastructure sectors. Prior to Frontieras, Moran served as Co-Founder and Vice President of Business Development at Yield Power Group, a project finance firm supporting energy and infrastructure projects ranging from $100 million to over $1 billion. She holds a Bachelor of Science in Political Science from the University of Wisconsin and serves on philanthropic and advisory boards.

José López, Chief Financial Officer, leads Frontieras’ financial strategy, operations, and capital planning. He brings over 20 years of experience in global finance and accounting, including senior roles at multinational public companies. López began his career at PwC’s external assurance practice, working across Houston, London, and The Hague. His background includes SEC reporting, corporate governance, FP&A, mergers and acquisitions, and capital markets transactions. He holds a Bachelor of Science in Accounting and Finance from the University of Houston–Clear Lake and is a licensed Certified Public Accountant.

Recent News

• Frontieras North America Inc. - InvestorNewsBreaks – Frontieras North America Highlights Antifragile Energy Strategy as Global Markets Face Historic Disruption
• InvestorNewsBreaks – Frontieras North America Marks Mason County Plant Groundbreaking With Ceremony in West Virginia
• InvestorNewsBreaks – Frontieras North America to Livestream April 2 Groundbreaking for First Commercial FASForm(TM) Plant

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO)

The QualityStocks Daily Newsletter would like to spotlight Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO).

Cardio Diagnostics Holdings (NASDAQ: CDIO) , a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence, has engaged IBN to support its corporate communications strategy as it advances blood-based solutions for the prevention and detection of cardiovascular disease. The company develops and commercializes clinical tests and data platforms that integrate molecular biomarkers with AI to generate patient-specific insights, including Epi+Gen CHD(TM), a prescription-only test for assessing three-year coronary heart disease risk, PrecisionCHD(TM) for detection and management, HeartRisk(TM) for population-level intelligence and CardioInnovate360(TM) to support cardiovascular therapy development.

To view the full press release, visit https://ibn.fm/hFqWS

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators.

At the core of its strategy is the integration of epigenetics, genetics, and artificial intelligence to generate insights from a patient’s molecular profile. By analyzing both inherited predisposition and changes influenced by lifestyle and environment, the company’s platform is designed to provide a more complete view of cardiovascular disease.

Cardio Diagnostics was founded to develop and commercialize clinical tests and data solutions that enable earlier detection and more precise management of cardiovascular disease across clinical and non-clinical settings.

The company is headquartered in Chicago, Illinois.

Portfolio

The company’s portfolio brings together epigenetic and genetic insights with artificial intelligence to generate actionable information for cardiovascular care. This approach underpins a suite of blood-based tests and platforms designed for use across both individual patient care and broader population health settings.

Epi+Gen CHD™

Epi+Gen CHD™ is a prescription-only blood test that assesses a patient’s three-year risk of a coronary heart disease (CHD) event, including heart attack and sudden death. The test evaluates three epigenetic and five genetic biomarkers and applies artificial intelligence to generate a personalized risk score. It is designed to assess risk regardless of the presence of traditional factors and is non-invasive, requiring no fasting or radiation. In clinical validation studies, the test has demonstrated approximately two times greater sensitivity than conventional risk calculators and enables ongoing monitoring through epigenetic biomarkers that can change in response to intervention.

PrecisionCHD™

PrecisionCHD™ is a prescription-only blood test that aids in the detection and management of coronary heart disease by identifying molecular signals associated with the condition. The test evaluates 10 epigenetic and six genetic biomarkers and uses artificial intelligence to determine whether a disease signal is present. It provides patient-specific insights into the molecular drivers of disease, supporting more individualized care decisions, and is designed to detect both obstructive and non-obstructive forms of CHD in a non-invasive manner.

HeartRisk™

HeartRisk™ is a population-level cardiovascular risk intelligence platform that integrates anonymized clinical, claims, industry, and geographic data to provide real-time insights into heart disease risk across defined populations. The platform enables organizations to quantify risk, project future healthcare costs, benchmark against peer groups, and track changes over time, supporting more informed planning and risk management strategies.

CardioInnovate360™

CardioInnovate360™ is a biopharma research platform that leverages artificial intelligence and epigenetics to support the discovery, development, and validation of cardiovascular therapies. The platform is designed to identify novel biomarkers and disease pathways, optimize clinical trial design through improved patient stratification, and enable the development of scalable, non-invasive diagnostic tools.

Market Opportunity

Cardiovascular disease (CVD) is the leading cause of death in the United States, responsible for nearly one in three deaths. It encompasses a range of conditions, including CHD, stroke, heart failure, and peripheral artery disease, and continues to represent a significant and persistent healthcare burden.

Coronary heart disease is the most common form of CVD and often develops without symptoms, with a heart attack frequently serving as the first indication of disease. In the U.S., one in 20 adults over the age of 20 lives with CHD, and it is the second leading cause of hospitalization, adding approximately $13,000 in annual healthcare costs per patient. An additional three to four million Americans are affected by ischemia with no obstructive coronary arteries (INOCA), a subset of CHD.

Heart attacks occur approximately every 40 seconds in the U.S., with more than 800,000 events annually, and one in five occurring without warning. While an estimated 80–90% of cardiovascular disease is preventable through early detection and proactive management, traditional approaches can leave gaps, as approximately 50% of individuals with coronary heart disease do not present with traditional risk factors and conventional risk calculators have an average sensitivity of 39%.

Leadership Team

Meesha Dogan, PhD, Chief Executive Officer and Co-Founder, has served as CEO and a director since inception and co-founded the company alongside Dr. Philibert. She has more than a decade of experience working at the intersection of artificial intelligence, epigenetics, and genetics, leading the development and commercialization of DNA-based cardiovascular tests. Dr. Dogan is an inventor on multiple granted and pending patents and holds a PhD in Biomedical Engineering and BSE/MS degrees in Chemical Engineering from the University of Iowa.

Robert Philibert, MD, PhD, Chief Medical Officer and Co-Founder, has served as CMO and a director since inception and co-founded the company with Dr. Dogan. He is a professor at the University of Iowa with joint appointments across psychiatry, neuroscience, molecular medicine, and biomedical engineering, and has published more than 200 peer-reviewed manuscripts. Dr. Philibert has received numerous NIH grants and holds patents related to epigenetics, including work on behavioral biomarkers.

Tim Dogan, PhD, Chief Technology Officer, has served as CTO since May 2022 after joining the company in 2019 as its first employee. He played a key role in developing the company’s Integrated Multi-Omics Engine™ and is a co-inventor on multiple patent-pending technologies. Dr. Dogan holds a PhD and BSE/MS degrees in Mechanical Engineering from the University of Iowa.

Elisa Luqman, JD, MBA, Chief Financial Officer, has served as CFO since March 2021 and has experience in public company finance, compliance, and corporate governance. She has held senior leadership roles at Clinigence Holdings Inc. and currently serves as Chief Legal Officer (SEC) at Nutex Health Inc., overseeing SEC reporting and compliance. Ms. Luqman holds a JD and MBA in Finance from Hofstra University.

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), closed Wednesday's trading session at $2.03, even for the day, on 202,755 volume. The average volume for the last 3 months is 354,712 and the stock's 52-week low/high is $0.97/$17.388.

Recent News

• Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) - BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Engages IBN to Support Corporate Communications Strategy
• Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Is 'One to Watch'
• BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026

GlobalTech Corp. (OTC: GLTK)

The QualityStocks Daily Newsletter would like to spotlight GlobalTech Corp. (OTC: GLTK).

GlobalTech (OTC: GLTK) reported fiscal 2025 net revenue of $22.1 million, representing a 21% increase from $18.3 million in 2024, driven by expansion across its telecommunications, broadband, technology services and retail segments. The company posted a net loss of $3.1 million as it continued investing in platform development, technology integration and operational infrastructure, while generating positive adjusted EBITDA of $0.89 million, reflecting underlying operating performance.

To view the full press release, visit https://ibn.fm/kaTV3

GlobalTech Corp. (OTC: GLTK) is a U.S.-based technology holding company specializing in artificial intelligence (AI), big data, and digital infrastructure. Advancing toward a Nasdaq listing, the company balances internal innovation with strategic acquisitions to accelerate growth and long-term value creation.

GlobalTech’s diversified portfolio spans AI-powered solutions for enterprise productivity, e-commerce, retail, digital lending, compliance, and other high-growth domains. Flagship platforms include ThrivoAI, Cadnz, Baseball Blitz, Talina, ProtoEd, BillCare, Giftio, and EntityScan. The company also holds a majority stake in WorldCall Telecom Ltd., extending its telecommunications presence in Pakistan and supporting infrastructure-led value creation.

To strengthen market reach, GlobalTech continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. Its partnership with significant regional players like Omantel anchors growth in the Middle East, a key gateway market. At the same time, the company’s Center of Excellence (CoE) and #GTCTalks knowledge platform position it as a thought leader in emerging technologies.

Supported by a seasoned leadership team and a disciplined execution model, GlobalTech is building sustainable momentum across global AI and big data markets, with the governance, innovation, and agility required to capture outsized opportunities in the digital economy.

GlobalTech Corp. (OTC: GLTK), closed Wednesday's trading session at $1.1099, off by 28.8526%, on 3,000 volume. The average volume for the last 3 months is 310 and the stock's 52-week low/high is $1.1/$3.4.

Recent News

• GlobalTech Corp. (OTC: GLTK) - TechMediaBreaks - GlobalTech Corp. (OTC: GLTK) Reports 21% Revenue Growth in Fiscal 2025
• InvestorNewsBreaks - GlobalTech Corp. (OTC: GLTK) Approved For OTCQB Venture Market Listing
• Anthropic Claims Chinese AI Companies are "Distilling" Claude

Datavault AI Inc. (NASDAQ: DVLT)

The QualityStocks Daily Newsletter would like to spotlight Datavault AI Inc. (NASDAQ: DVLT).

Datavault AI (NASDAQ: DVLT) announced it signed $750 million in aggregate tokenization contracts during the first quarter of 2026, generating approximately $77 million in associated fees across banking, IP licensing, minting and related services, supporting its previously stated full-year revenue guidance of at least $200 million. The contracts span multiple asset categories, including copper and gold mining, and come alongside the planned relaunch of the company’s core exchange platforms—Information Data Exchange (IDE), Sports Illustrated Exchange (SIx), New York Interactive Advertising Exchange (NYIAX) and International Elements Exchange (IEE)—which will feature enhanced AI-driven valuation, smart contracts and transparent trading capabilities as the company continues to scale its real-world asset tokenization infrastructure.

To view the full press release, visit https://ibn.fm/g0mD6

Datavault AI Inc. (NASDAQ: DVLT) is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio. WiSA Technologies delivers exceptional wireless sound experiences for high-definition content, including movies, music, sports, gaming, and esports, thereby enhancing the overall consumer experience in home entertainment.

As a founding member of WiSA™ (the Wireless Speaker and Audio Association), WiSA Technologies plays a critical role in defining wireless audio interoperability standards, ensuring seamless integration across devices and platforms. The company actively works with leading consumer electronics companies, technology providers, retailers, and ecosystem partners to promote and market spatial audio technologies, underscoring its commitment to advancing the future of audio and making high-quality, immersive sound accessible to a broader audience.

Headquartered in Beaverton, Oregon, WiSA Technologies extends its global reach with sales teams strategically located in Taiwan, China, Japan, Korea, and California. This international presence allows the company to effectively serve a diverse customer base and maintain strong relationships with key partners worldwide. By continuously innovating and setting new benchmarks in wireless audio, WiSA Technologies is well-positioned to remain at the forefront of the evolving home entertainment landscape.

The WiSA Association

The WiSA® Association, a wholly owned subsidiary of WiSA Technologies, is dedicated to promoting and standardizing spatial audio solutions for home entertainment, ensuring that immersive audio experiences are accessible to everyone. In collaboration with leading consumer electronics companies, technology providers, retailers, and ecosystem partners, the association works to advance wireless audio technology across various devices, making high-quality sound an integral part of modern home entertainment systems. As a key player in the industry, WiSA LLC, also known as the Wireless Speaker and Audio Association, is instrumental in fostering the adoption and integration of cutting-edge audio technologies.

Recently, the WiSA Association significantly expanded its influence by executing licensing agreements with leading HDTV brands, covering 43% of the HDTV market that uses the Android operating system, the most widely used OS in the market. By focusing on Android-based HDTVs and collaborating with speaker manufacturers, WiSA is actively building an ecosystem of WiSA E-enabled speaker systems, mirroring the success of its earlier WiSA HT technology. This strategic initiative, combined with WiSA E’s compatibility with multiple HDTV SoC providers and support for spatial audio formats like Dolby Atmos FlexConnect, positions the association at the forefront of transforming home audio experiences, driving widespread adoption across the home entertainment landscape.

Market Opportunity

From an investment perspective, WiSA Technologies Inc. is strategically positioned to capitalize on the growing demand for wireless and immersive audio experiences as consumer preferences shift toward high-definition home entertainment systems. As streaming services, gaming, and smart home technologies continue to expand, the need for seamless, high-quality audio solutions is becoming increasingly critical. WiSA Technologies, with its innovative wireless sound technology and strong partnerships with leading consumer electronics brands, is well-placed to capture a significant share of this expanding market, particularly as more consumers seek to enhance their home entertainment experiences.

Moreover, the company’s focus on setting industry standards through the WiSA Association further solidifies its role as a key player in the evolving audio landscape. By driving the adoption of wireless audio interoperability standards, WiSA Technologies not only ensures broad compatibility across devices but also positions itself as a leader in the market, capable of influencing future trends and technologies. This proactive approach, combined with its established global presence and collaborations with top-tier brands, provides WiSA Technologies with a strong foundation for sustained growth, making it an attractive opportunity for investors looking to gain exposure to the burgeoning home entertainment and smart audio sectors.

Leadership Team

Brett Moyer is the Chief Executive Officer, President, and Chairman of WiSA Technologies, Inc., and a founding member of the company. He has served in these leadership roles since August 2010. Prior to this, Mr. Moyer was the president and CEO of Focus Enhancements, Inc., where he oversaw the development and marketing of proprietary video technology. He has a rich background in consumer electronics, having held key positions at Zenith Electronics Inc., including Vice President and General Manager of its Commercial Products Division. Mr. Moyer also serves on the board of directors of Alliant International University and has previously served on the boards of HotChalk, Inc., and NeoMagic Corporation. He holds a Bachelor of Arts in Economics from Beloit College and an MBA in Finance and Accounting from Thunderbird School of Global Management.

Gary Williams is the Chief Accounting Officer and Vice President of Finance at WiSA Technologies, Inc., roles he has held since September 2019 and the company’s founding in August 2010, respectively. He previously served as the company’s Chief Financial Officer and Secretary until 2019. Mr. Williams has extensive experience in finance, having served as CFO of Quantum3D, Inc., and in similar roles at Focus Enhancements Inc. and Videonics Inc. He began his career in public accounting with Coopers & Lybrand LLP. Mr. Williams is a certified public accountant (inactive) and holds a bachelor’s degree in business administration with an emphasis in accounting from San Diego State University.

Datavault AI Inc. (NASDAQ: DVLT), closed Wednesday's trading session at $0.69, off by 0.790798%, on 35,631,110 volume. The average volume for the last 3 months is 45,354,064 and the stock's 52-week low/high is $0.2512/$4.1.

Recent News

• Datavault AI Inc. (NASDAQ: DVLT) - Web3MediaBreaks - Datavault AI Inc. (NASDAQ: DVLT) Secures $750M in Q1 Tokenization Contracts, Reinforces 2026 Revenue Outlook
• Labor Department, NSF Partner on Tech Access, AI Workforce
• MissionIRNewsBreaks - Datavault AI Inc. (NASDAQ: DVLT) CEO To Headline Major European Financial Innovation Events

Oncotelic Therapeutics Inc. (OTCQB: OTLC)

The QualityStocks Daily Newsletter would like to spotlight Oncotelic Therapeutics Inc. (OTCQB: OTLC).

• BluSky AI’s business plan includes rapidly deploying SkyMod data centers to meet growing demand for high-performance AI infrastructure
• The company operates at the intersection of modular data center design, energy optimization, and GPU-as-a-Service delivery
• The latest updates underscore the company’s broader goal: To empower organizations with flexible, scalable AI infrastructure without compromise

BluSky AI (OTC: BSAI) is strategically positioning itself at the forefront of a major shift in artificial intelligence infrastructure, where flexibility and predictable access to compute resources are becoming mission critical. With AI workloads increasing at unprecedented rates, organizations are changing their outlook on traditional hyperscale cloud providers and finding alternatives that reduce vendor lock-in, provide the compute that is quickly becoming unavailable, while enhancing cost visibility and performance reliability. The company’s approach, anchored in the design of modular and quickly deployable data centers, offers a compelling solution for this evolving landscape.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company developing RNA-based, immunotherapy, and targeted therapeutics for cancer and other underserved diseases. The company is focused on transforming outcomes for patients with difficult-to-treat and rare conditions, particularly pediatric cancers and aggressive solid tumors. Its development strategy centers on novel compound design, nanoparticle drug delivery, and the integration of artificial intelligence to accelerate discovery and regulatory workflows.

At the center of this foundation is Chairman and CEO Dr. Vuong Trieu, a prolific industry pioneer who has filed more than 500 patents with 75 issued patents across biologics, small molecules, nanoparticles, and diagnostics. Dr. Trieu co-invented Abraxane® (sold to Celgene for $2.9 billion), underscoring his track record of creating high-value therapies. Through collaborations with industry leaders and its stake in specialized joint ventures, Oncotelic is positioned to advance a diverse portfolio of oncology assets with greater speed and cost efficiency. The company also operates a proprietary AI platform, PDAOAI, which streamlines scientific writing, regulatory documentation, and data interpretation. This system is accessible to the public through a dedicated Discord server, offering real-time engagement with Oncotelic’s research ecosystem.

With expanded clinical activity and a next-generation development model, Oncotelic continues to evolve as a multi-asset innovator in precision oncology.

The company is headquartered in Agoura Hills, California.

Pipeline and Partnerships

Oncotelic’s lead candidate is OT-101, currently in a Phase 3 trial for pancreatic ductal adenocarcinoma (STOP-PC study) and evaluated in gliomas and metastatic solid tumors in combination with IL-2 and checkpoint inhibitors. The antisense molecule targets TGF-β2, a cytokine known to suppress immune responses and promote tumor growth. A Phase 1 trial combining OT-101 with IL-2 was recently completed, demonstrating safety and paving the way for combination therapies with PD-1 blockers and other immunotherapies.

Recent data have further strengthened the rationale for OT-101 in pancreatic ductal adenocarcinoma (PDAC). In June and July 2025, two peer-reviewed studies published in the International Journal of Molecular Sciences identified TGF-β2 gene expression and methylation status as significant prognostic markers in PDAC, particularly among younger patients and those with low CD8+ T-cell infiltration. High TGF-β2 expression correlated with reduced overall survival, while elevated TGF-β2 methylation was associated with improved outcomes. These findings validate TGF-β2 as a high-priority target and support the continued development of OT-101 as a precision therapy. Both studies leveraged Oncotelic’s proprietary AI-driven platform, PDAOAI, to mine and assemble multi-omic datasets, showcasing the system’s role in accelerating insight generation.

The company holds a 45% ownership stake in GMP Biotechnology Limited, a joint venture with Dragon Capital Overseas Limited. GMP Bio owns SAPU Bioscience, which is executing several pipeline programs. SAPU and Oncotelic are jointly utilizing a rapid IND platform through their partnership with Shanghai Medicilon to support regulatory filings for up to 20 drug candidates, with five INDs already underway. This collaboration is central to accelerating development of next-generation anticancer agents.

After the joint venture, Dr. Trieu, with his team, built out a state of the art and GMP-certified R&D facility in San Diego, which operates under SAPU, that manufactures clinical trial materials and supports a proprietary nanoparticle platform trademarked Deciparticle ™. This platform includes four therapeutic candidates—two of which are in late-stage manufacturing and expected to enter IND filing before the end of 2025.

Additionally, Oncotelic owns AL-101, an intranasal administered apomorphine product intended for the treatment of Parkinson’s disease, Erectile Dysfunction, and Female Sexual Disorders.

Market Opportunity

Oncotelic is targeting large and underserved therapeutic markets with significant commercial potentials. The global pancreatic cancer treatment market alone is projected to grow at a 12.3% CAGR, reaching $5.84 billion by 2030, up from $2.92 billion in 2024, according to Research and Markets. This growth is driven by increased disease prevalence, aging populations, and demand for more effective treatment options. Notably, the incidence of early-onset PDAC is rising at an estimated rate of 4% per year in the 15–34 age group, highlighting an emerging unmet need for targeted therapies among younger patients.

Beyond oncology, Oncotelic intends to develop AL-101 for Parkinson’s disease, which affects over 1 million patients in the U.S. alone and is expected to impact 1.2 million by 2030. Erectile Dysfunction and Female Sexual Dysfunction are also major global health issues, with Erectile Dysfunction affecting up to 70% of men over 60 and Female Sexual Dysfunction impacting approximately 40% of women—both with limited treatment options, particularly for patients who fail to respond to existing medications. These underserved populations offer fertile ground for innovative new therapies.

Leadership Team

Dr. Vuong Trieu is the Chairman and CEO of Oncotelic Inc. An accomplished innovator in pharmaceutical development, Dr. Trieu previously served as President and CEO of Igdrasol, where he pioneered the approval path for paclitaxel nanomedicine via a single bioequivalence trial. After Igdrasol merged with Sorrento Therapeutics, he became Chief Scientific Officer and a Board Director. He also held leadership roles at Cenomed, Abraxis, Applied Molecular Evolution, and Parker Hughes Institute. Dr. Trieu holds a Ph.D. in Molecular Microbiology, a B.S. in Botany, has published widely, and filed over 500 patent applications with 75 issued U.S. patents.

Amit Shah is the Chief Financial Officer of Oncotelic Inc. He has over 20 years of financial leadership in life sciences, including CFO roles at Marina Biotech and Igdrasol, and senior positions at ISTA Pharmaceuticals, Spectrum Pharmaceuticals, and Caraco. He also worked in consulting and ERP implementation. Mr. Shah holds a Bachelor of Commerce from the University of Mumbai, is an Associate Chartered Accountant in India, and is an inactive CPA in Colorado.

Dr. Anthony E. Maida III is the Chief Clinical Officer – Translational Medicine at Oncotelic Inc. He has over 25 years of experience advancing cancer immunotherapies and held senior roles at Northwest Biotherapeutics, PharmaNet, and Jenner Biotherapies. He has raised over $200 million for biotech firms and negotiated licensing deals with institutions such as Pfizer, Eli Lilly, and Yale. Dr. Maida holds dual B.A. degrees in Biology and History, an MBA, an M.A. in Toxicology, and a Ph.D. in Immunology, and is active in ASCO, AACR, and other scientific societies.

Oncotelic Therapeutics Inc. (OTCQB: OTLC), closed Wednesday's trading session at $0.0364, off by 1.8868%, on 458,911 volume. The average volume for the last 3 months is 247,330 and the stock's 52-week low/high is $0.015/$0.11.

Recent News

• Oncotelic Therapeutics Inc. (OTCQB: OTLC) - From Big Data to Better Drugs: How AI-Driven Platforms Are Changing Cancer Research
• AINewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in AINewsWire Editorial on AI-Driven Pharma Compliance
• BioMedNewsBreaks - Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Partners with TechForce Robotics to Advance AI-Enabled GMP Automation Platform

BluSky AI Inc. (OTC: BSAI)

The QualityStocks Daily Newsletter would like to spotlight BluSky AI Inc. (OTC: BSAI).

BluSky AI Inc. (OTC: BSAI) is pioneering the next generation of AI infrastructure through modular, rapidly deployable data centers that meet the escalating compute demands of artificial intelligence, machine learning, and high-performance computing. The company’s mission is to empower AI innovators by eliminating infrastructure bottlenecks and accelerating time-to-compute with energy-efficient, scalable solutions.

Rather than betting on individual AI applications, BluSky AI addresses the universal need for compute power—positioning itself as a foundational layer in the AI revolution. Its infrastructure-first approach enables clients to focus on innovation while the company delivers the critical backbone powering tomorrow’s breakthroughs.

BluSky AI is headquartered in Salt Lake City, Utah.

Products

BluSky AI’s core offering is its SkyMod series of modular data centers—pre-assembled, scalable compute units designed specifically for AI workloads. The flagship SkyMod One delivers 1 MW of compute power in a compact 1,400-square-foot footprint, while the SkyMod XL offers 1.7 MW in 3,000 square feet. These units are fully assembled off-site, tested, and shipped ready for plug-and-play deployment either on BluSky-owned land or client facilities.

SkyMod modules integrate NVIDIA GPUs and are optimized for high-density AI applications such as generative AI, large language models, inference engines, and scientific computing. Built for rapid scaling and high efficiency, each system includes advanced cooling, secure infrastructure, and dynamic workload balancing to support evolving client needs.

The company’s data centers are engineered for sustainability, incorporating renewable energy sources like solar, wind, and geothermal where available. By deploying on powered land assets, BluSky AI shortens lead times and lowers costs, creating a fast, flexible alternative to traditional monolithic data centers.

Market Opportunity

The global data center market was valued at $347.6 billion in 2024 and is projected to reach $652.0 billion by 2030, growing at a CAGR of 11.2%, driven by the rapid expansion of AI, machine learning, and IoT adoption, according to Grand View Research. As enterprises demand faster, more scalable compute solutions, modular infrastructure like BluSky AI’s SkyMod series offers a compelling alternative to legacy data center models.

With North America accounting for over 40% of the global market and the U.S. expected to grow at a 10.7% CAGR from 2025 to 2030, BluSky AI is well-positioned to capture demand for AI-optimized infrastructure that can be deployed rapidly and cost-effectively. By focusing on GPU-centric, modular deployments tied to energy infrastructure, the company addresses a growing gap between compute demand and deployment speed in the AI era.

Leadership Team

Trent D’Ambrosio, Chief Executive Officer, is a seasoned executive with a track record in telecommunications, hedge fund management, and natural resource development. He previously sold the first transatlantic fiber cable, built a successful gold mining company, and now leads BluSky AI with a vision to revolutionize AI infrastructure through strategic energy integration and rapid deployment.

Julien Bedard, Chief Technology Officer, is a pioneering technologist known for launching the first Bitcoin escrow and anti-fraud service. At BluSky AI, he oversees cloud architecture, cybersecurity, infrastructure automation, and the development of AI-native data center technology, ensuring scalability and resilience across deployments.

Dan Gay, Chief Operating Officer, has Fortune 500 executive leadership in telecom, technology, and energy, as well as start-up experience with finance and blockchain companies. At MCI and Qwest, he launched new service and sales centers, and directed National Account Sales. He has been a successful CMO in brand creation, product development, partnerships, and revenue generation programs to expand company awareness, sales, and revenue.

BluSky AI Inc. (OTC: BSAI), closed Wednesday's trading session at $3.7, up 20.1299%, on 162 volume. The average volume for the last 3 months is 300 and the stock's 52-week low/high is $0.0003/$17.97.

Recent News

• BluSky AI Inc. (OTC: BSAI) - BluSky AI Inc. (BSAI) Outlines Strategy to Tackle GPU Bottlenecks with Modular Distributed Neocloud Infrastructure
• AINewsBreaks - BluSky Ai Inc. (OTCID: BSAI) Featured in Research Report Highlighting Scalable GPU-Centric AI Platform
• InvestorNewsBreaks - BluSky AI Inc. (OTCID: BSAI) Signs Strategic Partnership With Kwieri to Integrate AI Infrastructure and Human-Centered Learning

Earth Science Tech Inc. (OTC: ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech Inc. (OTC: ETST).

Earth Science Tech Inc. (OTC: ETST) is a strategic holding company that builds value by acquiring and actively managing operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets. The company focuses on controlling interests in subsidiaries where operational oversight, regulatory compliance, and disciplined scaling can drive durable growth.

Since 2022, Earth Science Tech has completed a deliberate transition away from legacy activities and repositioned the organization around healthcare and pharmaceutical operations. That shift has been supported by regulatory alignment, expanding operating capabilities, and the assembly of a diversified portfolio of revenue-generating businesses.

Today, the company’s approach emphasizes execution, capital discipline, and long-term value creation across its operating platforms, with a focus on scaling businesses that can grow sustainably while enhancing shareholder value.

The company is headquartered in Miami, Florida.

Subsidiaries

Earth Science Tech conducts its operations through a portfolio of wholly owned and majority-owned subsidiaries spanning pharmaceutical compounding, telemedicine, healthcare services, real estate development, and direct-to-consumer products.

• RxCompoundStore.com LLC – A fully licensed compounding pharmacy based in Miami, Florida, authorized to fulfill prescriptions across more than 20 U.S. states and Puerto Rico, with ongoing licensure expansion efforts nationwide.
• Mister Meds LLC – A Texas-based compounding pharmacy operating from a 5,000-square-foot facility with advanced sterile and hazardous drug compounding capabilities, acquired to expand production capacity and geographic reach.
• Peaks Curative LLC – A telemedicine referral platform providing asynchronous consultations for Peaks-branded compounded medications, supported by an expanding provider network and recent entry into the veterinary market through Zoolzy.com.
• DOConsultations LLC – An online telehealth platform focused on customized medication formulations, supporting direct-to-patient delivery through partner pharmacies.
• Las Villas Health Care Inc. – A brick-and-mortar and telehealth healthcare provider serving the Spanish-speaking community, offering specialized wellness and sexual health services.
• Avenvi LLC – A diversified real estate development and asset management company overseeing property investments, development projects, and the company’s ongoing share repurchase program.
• MagneChef (80% interest) – A direct-to-consumer retail brand leveraging proprietary intellectual property to develop and market kitchen and cooking-related products, with recent expansion into premium American-made BBQ tools.
• Earth Science Foundation Inc. – A 501(c)(3) nonprofit organization serving as the company’s charitable arm, providing financial assistance for prescription costs to qualified individuals.

Collectively, these subsidiaries provide Earth Science Tech with diversified exposure across regulated healthcare services, digital health platforms, real estate assets, and proprietary consumer brands.

Market Opportunity

Earth Science Tech is primarily positioned within the pharmaceutical compounding and telemedicine markets, both of which are experiencing sustained growth driven by demand for personalized healthcare solutions, expanded access to care, and increasing adoption of remote service models.

The pharmaceutical compounding market continues to benefit from rising demand for customized medications, improved patient adherence, and supply-chain flexibility. According to Grand View Research, the global compounding pharmacies market was valued at approximately $13.1 billion in 2023 and is projected to reach $18.6 billion by 2030, representing a compound annual growth rate of 5.11% from 2024 to 2030. Earth Science Tech’s compounding operations through RxCompoundStore.com and Mister Meds align directly with this expanding market segment.

Telemedicine represents a second core growth vertical for the company, supporting the clinical delivery of pharmaceutical products and healthcare services. According to Fortune Business Insights, the global telemedicine market was valued at $111.99 billion in 2025 and is projected to grow to $532.08 billion by 2034, reflecting a compound annual growth rate of 20.0%, with North America accounting for approximately 48% of market share in 2025. Platforms operated by Peaks Curative and DOConsultations participate directly in this rapidly expanding digital health ecosystem.

Additional exposure to specialty healthcare clinics and real estate development provides diversification alongside the company’s core pharmaceutical and telemedicine operations.

Leadership Team

Giorgio R. Saumat, Chief Executive Officer and Chairman of the Board, is an investor and entrepreneur with more than 20 years of experience investing in, operating, and advising private businesses, including founding CASAU Group, a private equity firm focused on real estate, and POINT96 Consulting, which provides strategic planning services to businesses and accredited investors.

Ernesto L. Flores, Chief Financial Officer, is a financial executive with over a decade of experience in accounting, taxation, and financial management, having held senior roles overseeing compliance and financial operations at logistics and investment firms.

Mario G. Tabraue, President and Chief Operating Officer, brings experience across real estate, maritime operations, and digital infrastructure and was instrumental in acquiring RxCompoundStore.com with the vision of scaling it into a nationally competitive pharmaceutical and telemedicine platform.

Christopher Rose, Chief Technology Officer, is a technology and automation executive who previously led enterprise-wide automation initiatives at a Fortune 100 company, delivering large-scale operational efficiencies and global process automation.

Earth Science Tech Inc. (OTC: ETST), closed Wednesday's trading session at $0.104, up 15.5556%, on 148,510 volume. The average volume for the last 3 months is 84,040 and the stock's 52-week low/high is $0.001/$0.237.

Recent News

• Earth Science Tech Inc. (OTC: ETST) - Earth Science Tech Inc. (ETST) Builds Integrated Healthcare Platform for Scalable Growth
• BioMedNewsBreaks - Earth Science Tech, Inc. (OTC: ETST) Launches MyOnlineConsultation Platform Through MOCTeledoc
• Earth Science Tech Inc. (ETST) Builds Telehealth, Pharmacy Links in Evolving Digital Care

Perpetuals.com Ltd. (NASDAQ: PDC)

The QualityStocks Daily Newsletter would like to spotlight Perpetuals.com Ltd. (NASDAQ: PDC).

Perpetuals.com Ltd. (NASDAQ: PDC) is a publicly traded, regulated digital market infrastructure company enabling derivatives trading through a compliant, API-driven platform. Built as infrastructure rather than a balance-sheet exchange, the company provides brokers, institutions, and trading venues with regulated access to crypto and tokenized derivatives while avoiding custody, credit, and counterparty exposure by design.

The platform addresses a structural gap created as demand for leveraged digital asset exposure has outpaced the availability of compliant market infrastructure, particularly in Europe. Regulatory constraints limit how traditional brokers can legally offer crypto leverage, while many existing trading venues operate outside regulated frameworks. Perpetuals is designed to function within these constraints by combining institutional-grade execution, real-time settlement, and structured product capabilities under an EU-regulated market framework.

By operating as a regulated trading venue and infrastructure provider, Perpetuals enables market participants to access derivatives through transparent and auditable systems rather than offshore or unregulated alternatives.

Platform & Infrastructure

Perpetuals operates a regulated hybrid exchange built on proprietary infrastructure and structured around an EU Multilateral Trading Facility (MTF) framework. The platform is designed as institutional trading infrastructure, incorporating a high-speed matching engine, real-time settlement, built-in compliance and surveillance, and a hybrid architecture that delivers centralized exchange performance with blockchain-based transparency.

The platform is API-native by design, enabling direct integration with CFD brokers, institutional counterparties, and trading venues. Through turnkey APIs, partners can integrate order routing, execution, structured product issuance, market data, settlement, risk management, and compliance reporting, while the platform is designed to avoid custody of client assets and balance-sheet exposure. This infrastructure-first model allows Perpetuals to function as a regulated trading venue rather than a trading counterparty.

On top of this infrastructure, the platform is designed to support crypto spot trading, perpetual futures, futures, options, swaps, and tokenized structured products, including regulated knock-out instruments intended to operate within European regulatory constraints. Perpetuals also incorporates a prediction and insight engine designed to reward accurate market signals while generating datasets used to refine pricing, risk parameters, and trading intelligence across its structured products.

Market Opportunity

Perpetuals operates at the intersection of several large and converging markets, including crypto derivatives, regulated trading infrastructure, CFD brokerage technology, and tokenized financial products. The global crypto perpetual futures market processes approximately $2.18 trillion in monthly trading volume, while Europe’s CFD market generates roughly $17.34 trillion in monthly notional volume from approximately 4.9 million active retail accounts.

European regulatory frameworks restrict CFD brokers from legally offering high-leverage crypto products, creating a significant gap between trader demand and compliant market access. As a result, demand for crypto leverage has outpaced the availability of regulated infrastructure capable of serving brokers and institutional participants. This dynamic has left a large segment of retail and professional trading activity without compliant, onshore solutions.

Perpetuals addresses this gap by enabling regulated knock-out and structured products that allow leveraged crypto exposure without breaching leverage caps. In parallel, the emergence and adoption of tokenized financial instruments and real-world assets have increased demand for compliant, multi-asset trading venues. By operating within a regulated MTF framework and supporting tokenized issuance and trading, Perpetuals enables participation in the ongoing institutional adoption of digital asset markets without reliance on offshore or unregulated systems.

Leadership Team

Patrick Gruhn is an entrepreneur, lawyer, software engineer, and fintech innovator with more than two decades of experience across technology, law, and financial markets in Europe and the United States. He has founded and scaled multiple technology companies spanning tokenized securities, legal technology, and digital infrastructure, including businesses later acquired by major industry participants. His work focuses on the intersection of blockchain, regulation, and artificial intelligence. Gruhn is also actively involved in academic and institutional initiatives related to digital innovation.

Robin Matzke is a legal and regulatory specialist with deep expertise in digital securities, tokenization, and market structure. He has founded and advised companies operating at the intersection of law and financial technology and has contributed to the development of legal frameworks for digital assets in Europe. His background includes doctoral research on virtual stock structures and extensive academic teaching and publication. Matzke has also served as an advisor on digital securities regulation at the legislative level.

Nayia Ziourti is a regulatory lawyer with more than 15 years of experience in European financial services regulation, compliance strategy, and governance. She has held senior legal and regulatory roles across both public authorities and private financial institutions, including leadership positions within EU-regulated digital asset entities. Her experience includes direct involvement with EU policy development, ESMA initiatives, and MiFID-related regulatory frameworks. Ziourti brings deep institutional knowledge of compliance implementation across complex jurisdictions.

Sean Prescott is a technologist and financial infrastructure architect with over 20 years of experience spanning fintech, cybersecurity, encryption, and decentralized systems. His background includes designing institutional trading infrastructure, secure settlement systems, and large-scale financial platforms across Europe, the Middle East, and North America. He has developed proprietary transaction and custody architectures used by governments, enterprises, and digital asset platforms. Prescott’s focus is on building secure, scalable infrastructure for regulated digital finance.

Stephen Stephens is a senior operations and technology executive with extensive experience scaling complex fintech, regtech, and enterprise platforms. His career includes leading global delivery teams, managing multimillion-dollar programs, and transitioning advanced technologies into stable operating environments. He brings expertise in operational execution, platform integration, and enterprise process management across regulated industries. Stephens has overseen large-scale implementations spanning trading systems, ERP platforms, and compliance-driven operations.

Aaron Rudder is a finance and economics professional focused on developing fairer and more efficient capital markets through regulated digital infrastructure. He brings experience across crypto finance, derivatives research, and tokenized market structures, including work within EU-regulated trading environments. Rudder has led research initiatives supporting compliant derivatives issuance and structured digital asset products. His background combines financial modeling, market analysis, and applied research at the intersection of regulation and emerging financial systems.

Perpetuals.com Ltd. (NASDAQ: PDC), closed Wednesday's trading session at $5.05, up 10.989%, on 51,267 volume. The average volume for the last 3 months is 27,327 and the stock's 52-week low/high is $1.64/$10.5.

Recent News

• Perpetuals.com Ltd. (NASDAQ: PDC) - Perpetuals.com Ltd. (NASDAQ: PDC) to Present AI-Driven Trading Platform at Emerging Growth Conference
• TechMediaBreaks - Perpetuals.com Ltd. (NASDAQ: PDC) Secures CySEC Approval To Expand MiFID II License
• InvestorNewsBreaks - Perpetuals.com Ltd. (NASDAQ: PDC) CEO To Present At Emerging Growth Conference